CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale Chief Commercial Officer sold 298 shares at $8.15 ($2,428)
- 4 Open-market sale President & CEO sold 970 shares at $8.15 ($7,905)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 298 shares at $8.15 ($2,428)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 1,143 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 13 shares at $7.62 ($99)
- 4 Open-market sale Chief Development Officer sold 23 shares at $7.62 ($175)
- 4 Open-market sale Chief Commercial Officer sold 25 shares at $7.62 ($191)
- 4 Open-market sale President & CEO sold 189 shares at $7.62 ($1,440)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 50 shares at $7.62 ($381)
- 4 Option exercise Director acquired 1,144 shares (option exercise)
Page 2 of 17 · 336 filings